Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Mateos-Rodriguez

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Endoscopy|October 25, 2011
Migrated surgical clip-induced choledocholithiasisJ Molina-Infante, M Fernandez-Bermejo, J M Mateos-Rodriguez
Endoscopy|September 27, 2012
Recurrent rectosigmoid volvulus and fatal peritonitis after percutaneous endoscopic sigmoidostomyJ Molina-Infante, M Fernandez-Bermejo, J M Mateos-Rodriguez
Gut|March 7, 2007
Octreotide LAR for severe obscure-overt gastrointestinal haemorrhage in high-risk patients on anticoagulation therapyJ Molina-Infante, B Perez-Gallardo, G Gonzalez-Garcia, et al.
Alimentary Pharmacology & Therapeutics|February 26, 2010
Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradicationJ Molina-Infante, B Perez-Gallardo, M Fernandez-Bermejo, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Endoscopy|October 25, 2011
Migrated surgical clip-induced choledocholithiasisJ Molina-Infante, M Fernandez-Bermejo, J M Mateos-Rodriguez
Endoscopy|September 27, 2012
Recurrent rectosigmoid volvulus and fatal peritonitis after percutaneous endoscopic sigmoidostomyJ Molina-Infante, M Fernandez-Bermejo, J M Mateos-Rodriguez
Gut|March 7, 2007
Octreotide LAR for severe obscure-overt gastrointestinal haemorrhage in high-risk patients on anticoagulation therapyJ Molina-Infante, B Perez-Gallardo, G Gonzalez-Garcia, et al.
Alimentary Pharmacology & Therapeutics|February 26, 2010
Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradicationJ Molina-Infante, B Perez-Gallardo, M Fernandez-Bermejo, et al.
Pageof 1